Related Experiment Video

Updated: Aug 7, 2026

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

Mycophenolate mofetil for lupus related myelopathy

C C Mok, A Mak, C H To

    Annals of the Rheumatic Diseases
    |June 14, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
    07:17

    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

    Published on: January 29, 2021

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Myasthenia Gravis: Overview and Treatment01:20

    Myasthenia Gravis: Overview and Treatment

    Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
    These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

    Articles linked to this work by shared authors, journal, and citation graph.

    Building social equity and person-centred innovation into the end TB response.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024

    iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus.

    Lupus science & medicine·2024

    Minimally invasive rehabilitation of the worn dentition: a case report utilising adhesive additive techniques and digital technologies.

    Australian dental journal·2019

    Systemic lupus erythematosus: what should family physicians know in 2018?

    Hong Kong medical journal = Xianggang yi xue za zhi·2018

    Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

    Journal of autoimmunity·2018

    Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus.

    Vaccine·2018

    Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

    Annals of the rheumatic diseases·2026

    Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.

    Annals of the rheumatic diseases·2026

    Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

    Annals of the rheumatic diseases·2026

    High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

    Annals of the rheumatic diseases·2026

    Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.

    Annals of the rheumatic diseases·2026

    Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis using a consensus and data-driven approach.

    Annals of the rheumatic diseases·2026

    Upregulation of CREB1 by Mycobacterium Tuberculosis Transcriptionally Activates TREM2 to Promote Macrophage M2 Polarization.

    Cell biochemistry and function·2026

    Medication Adherence Across Diseases Using the 8-Item Morisky Medication Adherence Scale (MMAS-8): A Systematic Review With Narrative Synthesis.

    Cureus·2026

    Mediterranean diet and health outcomes in idiopathic inflammatory myopathies.

    Rheumatology (Oxford, England)·2026

    Isolation and characterization of an algicolous endophytic Mucor circinelloides from macroalga Colpomenia sinuosa as a promising source of bioactive metabolites for dermocosmetic applications.

    Scientific reports·2026

    Agranulocytosis associated with metamizole among EudraVigilance reports involving methotrexate for rheumatoid arthritis.

    Naunyn-Schmiedeberg's archives of pharmacology·2026

    Genomic determinants of morphotype transition and biofilm formation in clinical Mycobacterium abscessus isolates.

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us